These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 22813562)

  • 1. Prevalence of hypertension, control of blood pressure and treatment in hypertensive with type 2 diabetes in Hospital University Sains Malaysia.
    Abougalambou SS; Abougalambou AS; Sulaiman SA; Hassali MA
    Diabetes Metab Syndr; 2011; 5(3):115-9. PubMed ID: 22813562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thailand diabetes registry project: prevalence of hypertension, treatment and control of blood pressure in hypertensive adults with type 2 diabetes.
    Bunnag P; Plengvidhya N; Deerochanawong C; Suwanwalaikorn S; Kosachunhanun N; Benjasuratwong Y; Krittiyawong S; Leelawatana R; Pratipanawatr T; Ngarmukos C; Chetthakul T; Puavilai G; Mongkolsomlit S; Rawdaree P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S72-7. PubMed ID: 17715837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors of microalbuminuria in type 2 diabetes mellitus outpatients at University Sains Malaysia Hospital.
    Abougalambou SS; Abougalambou AS
    Diabetes Metab Syndr; 2013; 7(2):64-7. PubMed ID: 23680242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study evaluating prevalence of hypertension and risk factors affecting on blood pressure control among type 2 diabetes patients attending teaching hospital in Malaysia.
    Abougalambou SS; Abougalambou AS
    Diabetes Metab Syndr; 2013; 7(2):83-6. PubMed ID: 23680246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
    Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
    G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
    Guo QH; Pan CY; Qi WH; Lin SY;
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes mellitus with hypertension at primary healthcare level in Malaysia: are they managed according to guidelines?
    Chan GC
    Singapore Med J; 2005 Mar; 46(3):127-31. PubMed ID: 15735877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure control among diabetic hypertensives under cardiology follow-up at a regional hospital in rural Malaysia.
    Azarisman SM; Aszrin A; Marzuki AO; Fatnoon NN; Hilmi A; Hadzri MH; Ngow PH; Shah A; Rathor MY; Jamalludin AR
    Southeast Asian J Trop Med Public Health; 2010 Jul; 41(4):973-81. PubMed ID: 21073073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial hypertension management in patients with type 2 diabetes].
    Charpentier G; Genès N; Vaur L; Clerson P; Amar J; Guéret P; Cambou JP
    Arch Mal Coeur Vaiss; 2002; 95(7-8):661-5. PubMed ID: 12365076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
    Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
    Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of blood pressure control among hypertensive patients on follow-up in a regional referral hospital in Central Kenya.
    Mutua EM; Gitonga MM; Mbuthia B; Muiruri N; Cheptum JJ; Maingi T
    Pan Afr Med J; 2014; 18():278. PubMed ID: 25489372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
    Román O; Cuevas G; Bunout D
    Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension audit in clinical practice based in Thailand (HABIT).
    Buranakitjaroen P
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S57-65. PubMed ID: 21721429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes.
    Savage S; Johnson Nagel N; Estacio RO; Feig PU; MacCarthy EP; Lukken NJ; Ziegler R; Schrier RW
    Online J Curr Clin Trials; 1993 Nov; Doc No 104():[6250 words; 128 paragraphs]. PubMed ID: 8305994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.